Dr Shari Lyn Barrett, MD | |
3700 Bellemeade Ave, Suite 120, Evansville, IN 47714-0102 | |
(812) 473-0200 | |
(812) 473-3640 |
Full Name | Dr Shari Lyn Barrett |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 3700 Bellemeade Ave, Evansville, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245251990 | NPI | - | NPPES |
000000333630 | Other | IN | ANTHEM/BLUE SHIELD |
100247290A | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 01033182 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Shari Lyn Barrett, MD 3700 Bellemeade Ave, Suite 120, Evansville, IN 47714-0102 Ph: (812) 473-0200 | Dr Shari Lyn Barrett, MD 3700 Bellemeade Ave, Suite 120, Evansville, IN 47714-0102 Ph: (812) 473-0200 |
News Archive
The Association for Molecular Pathology, the premier global, non-profit organization serving molecular diagnostic professionals, today announced a new report that addresses the challenges in defining the clinical utility of molecular diagnostics for inherited diseases and cancer.
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.
A new study in Journal of Bone and Mineral Research looked at the relative contributions of the two types of bone-cortical, or compact bone, and trabecular, or spongy bone-to total bone loss.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.
In a study that included nearly 60,000 patients with acute ischemic stroke, thrombolytic treatment (to help dissolve a blood clot) that was started more rapidly after symptom onset was associated with reduced in-hospital mortality and intracranial hemorrhage and higher rates of independent walking ability at discharge and discharge to home, according to a study in the June 19 issue of JAMA.
› Verified 3 days ago
Jon C Davis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 120 Se 4th St, Evansville, IN 47708 Phone: 812-426-9355 Fax: 812-858-4539 | |
Vanessa M Mischler, NP Dermatology Medicare: Medicare Enrolled Practice Location: 1212 Professional Blvd Ste B, Evansville, IN 47714 Phone: 812-401-9030 Fax: 812-401-9033 | |
Robert William Martin Iii, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 421 Chestnut St, Evansville, IN 47713 Phone: 812-426-9355 Fax: 812-858-4539 | |
Jeffrey Keith Moore, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 421 Chestnut St, Evansville, IN 47713 Phone: 812-426-9355 Fax: 812-858-4539 | |
David Surprenant, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 120 Se 4th St, Evansville, IN 47708 Phone: 812-463-4306 | |
Dr. Charles P Hudson, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3501 Washington Ave, Evansville, IN 47714 Phone: 812-474-1234 Fax: 812-402-3636 |